SIGA Technologies Inc. — Earnings Quality Grade B
SIGA · Healthcare
Generally healthy
Screening Summary
Management Signals
Financial Trends
Revenue & Net Income ($B)
Margins (%)
18-Point Screening
Revenue Quality
DSO 13 days, change -43 days YoY
AR growth -84.6% vs revenue growth -31.8%
Revenue -31.8%, CFFO -10.8%. Cash follows revenue
Expense Quality
Inventory -1.0% vs COGS 13.9%. Normal
CapEx growth 736.3% is >2x revenue growth -31.8%
SG&A/Gross Profit = 47.2%. Normal
Gross margin swung -21.1pp (68.6% → 47.5%)
Cash Flow Quality
CFFO/NI = 1.87. Profits backed by cash
FCF $0.0B, FCF/NI = 1.85
Accruals ratio = -9.2%. Low accruals
Cash $0.2B covers debt $0.0B
Balance Sheet Health
Goodwill+Intangibles $0.0B = 0% of equity. Manageable
Debt/EBITDA = 0.0x. Healthy
Other assets -19.9% vs revenue -31.8%. Normal
No write-off data
Acquisition Risk
FCF after acquisitions positive
Goodwill+Intangibles change 0% YoY. Normal
Manipulation Score
M-Score = -3.86 (< -2.22). Unlikely manipulator
Portfolio monitoring
Monitor SIGA continuously
The full checks and model details are free to read. Use Watchlist to track your holdings; Pro adds automatic quarterly rescoring, risk-event email alerts, scans up to 50 tickers, and export workflows.
Beneish M-Score
Altman Z-Score
Generated from public financial data using forensic accounting frameworks. Not investment advice. Data: Yahoo Finance · 2026-04-25